Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,661 | 2,537 | 2,836 | 2,503 | 1,748 |
| Operating Income | -2,661 | -2,537 | -2,836 | -2,503 | -1,748 |
| Other Income | 55 | 64 | 89 | 111 | 119 |
| Pre-tax Income | -2,607 | -2,473 | -2,747 | -2,392 | -1,628 |
| Net Income Continuous | -2,607 | -2,473 | -2,747 | -2,392 | -1,628 |
| Net Income | $-2,607 | $-2,473 | $-2,747 | $-2,392 | $-1,628 |
| EPS Basic Total Ops | -0.20 | -0.19 | -0.20 | -0.19 | -0.13 |
| EPS Basic Continuous Ops | -0.20 | -0.19 | -0.21 | -0.19 | -0.13 |
| EPS Diluted Total Ops | -0.20 | -0.19 | -0.20 | -0.19 | -0.13 |
| EPS Diluted Continuous Ops | -0.20 | -0.19 | -0.21 | -0.19 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.19 | -0.21 | N/A | N/A |
| EBITDA(a) | $-2,661 | $-2,536 | $-2,835 | $-2,502 | $-1,747 |